Market Overview

26 Stocks Moving in Monday's Pre-Market Session

Share:
26 Stocks Moving in Monday's Pre-Market Session

Gainers

  • Digital Ally, Inc. (NASDAQ: DGLY) rose 185.7% to $3.20 in pre-market trading after surging over 33% on Friday.
  • Cemtrex, Inc. (NASDAQ: CETX) shares rose 120.7% to $2.09 in pre-market trading.
  • Vislink Technologies, Inc. (NASDAQ: VISL) rose 50% to $0.4399 in pre-market trading. Vislink Technologies posted a Q1 loss of $0.09 per share on Thursday.
  • Liquid Media Group Ltd. (NASDAQ: YVR) shares rose 43.8% to $2.20 in pre-market trading.
  • Immutep Limited (NASDAQ: IMMP) rose 36.7% to $1.68 in pre-market trading after the company disclosed improving results from the Phase II TACTI-002 study. The company also reported first interim data from its INSIGHT-004 study.
  • Wrap Technologies, Inc. (NASDAQ: WRTC) rose 23.8% to $7.98 in pre-market trading after surging over 27% on Friday.
  • Allied Esports Entertainment Inc. (NASDAQ: AESE) rose 22.5% to $3.00 in pre-market trading after gaining around 34% on Friday.
  • Aytu BioScience, Inc. (NASDAQ: AYTU) rose 17.4% to $1.75 in pre-market trading after gaining over 6% on Friday. HC Wainwright & Co. initiated coverage on Aytu BioScience with a Buy rating and a price target of $3 on Friday.
  • Minerva Neurosciences, Inc. (NASDAQ: NERV) rose 16.2% to $4.31 in pre-market trading. Minerva Neurosciences shares tumbled over 72% on Friday after the company reported results from Phase 3 Trial of Roluperidone for the treatment of negative symptoms in schizophrenia.
  • AgEagle Aerial Systems, Inc. (NYSE: UAVS) rose 16% to $1.38 in pre-market trading.
  • Micro Focus International plc (NYSE: MFGP) rose 8% to $5.38 in pre-market trading after dropping around 12% on Friday.
  • Virgin Galactic Holdings, Inc. (NYSE: SPCE) rose 7.4% to $18.30 in pre-market trading.
  • ACM Research, Inc. (NASDAQ: ACMR) rose 6.7% to $63.77 in pre-market trading.
  • Coty Inc (NYSE: COTY) rose 6.6% to $3.87 in pre-market trading. Coty will name Chairman Peter Harf as CEO, the Wall Street Journal reported.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Ascena Retail Group, Inc. (NASDAQ: ASNA) fell 40.1% to $1.00 in pre-market trading. Ascena Retail shares fell around 15% on Friday after reporting a 45% decline in Q3 sales..
  • Nabriva Therapeutics plc (NASDAQ: NBRV) fell 15% to $0.97 in pre-market trading. Nabriva Therapeutics reported a $38 million registered direct offering priced at-the-market under Nasdaq rules.
  • ARCA biopharma, Inc. (NASDAQ: ABIO) shares fell 13.8% to $10.86 in pre-market trading after dropping 34% on Friday. ARCA biopharma shares climbed 386% on Thursday after the company announced the development program for its AB201 treatment of coronavirus associated with coagulopathy.
  • Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares fell 11% to $2.20 in pre-market trading. Comstock shares jumped 24% on Friday after reporting Q1 results.
  • Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP) fell 10.5% to $9.91 in pre-market trading after announcing a public offering of 12.5 million American Depositary Shares.
  • CBL & Associates Properties, Inc. (NYSE: CBL) fell 9.4% to $0.2701 in pre-market trading after dropping about 8% on Friday.
  • Creative Realities, Inc. (NASDAQ: CREX) fell 8.8% to $2.30 in pre-market trading.
  • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) fell 8.7% to $1.05 in pre-market trading after declining over 6% on Friday.
  • Menlo Therapeutics Inc. (NASDAQ: MNLO) fell 7.1% to $2.22 in pre-market trading. On Friday, Menlo Therapeutics reported the FDA approval for ZILXI topical foam, 1.5% for rosacea.
  • CHF Solutions, Inc. (NASDAQ: CHFS) fell 6.7% to $0.35 in pre-market trading.
  • Target Corporation (NYSE: TGT) shares fell 6% to $115.01 in pre-market trading. Target, late Saturday, announced plans to shutter 175 stores and reduce hours at a few others until further notice following the protests organized in the wake of George Floyd's death.
  • Pfizer Inc. (NYSE: PFE) fell 5.8% to $35.90 in pre-market trading after disappointing news concerning its Phase 3 early breast cancer Palbociclib Collaborative Adjuvant Study (PALLAS) trial results.
 

Related Articles (ABIO + ACMR)

View Comments and Join the Discussion!

Posted-In: Premarket MoversNews Penny Stocks Pre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com